Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma

被引:170
作者
Lu, Juan [1 ]
Liu, Qi-Hui [1 ]
Wang, Fan [1 ]
Tan, Jia-Jie [1 ]
Deng, Yue-Qin [1 ]
Peng, Xiao-Hong [1 ]
Liu, Xiong [1 ]
Zhang, Bao [2 ]
Xu, Xia [3 ]
Li, Xiang-Ping [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Otolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China
[3] Peoples Liberat Army, Guangzhou Gen Hosp, Dept Otolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Exosome; miR-9; Angiogenesis; MDK; Nasopharyngeal carcinoma; MIDKINE; CANCER; CELLS; BIOMARKER; PROMOTES;
D O I
10.1186/s13046-018-0814-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Exosomes are small vesicles containing a wide range of functional proteins, mRNA and miRNA. Exosomal miRNAs from cancer cells play crucial roles in mediating cell-cell communication and tumor-microenvironment cross talk, specifically in enabling metastasis and promoting angiogenesis. We focused on miR-9 that was identified as a tumor suppressor previously in nasopharyngeal carcinoma (NPC) tumorigenesis. Methods: Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and identify exosomes. Quantitative PCR and western blotting analysis were used to detect miR-9, pri-miR-9, CD63, TSG101, MDK, P70S6K P-Ser424 and PDK1 P-Ser241 expression. Laser confocal microscopy was used to trace exosomal miR-9 secreted by NPC cells into HUVECs. The effect of exosomal miR-9 on cell migration and tube formation of HUVECs in vivo and vitro was assessed by using migration assay, tube formation assay and matrigel plug assay, respectively. Bioinformatics analysis and luciferase reporter assay were utilized to confirm the binding of exosomal miR-9 to the 3' untranslated region (3'-UTR) of MDK, while Phosphorylation Array was performed to identify AKT Pathway in HUVECs treated with exosomal miR-9. Furthermore, Immunohistochemistry (IHC) and in situ hybridization (ISH) was used to detected miR-9, CD31 and MDK expression in human NPC tumor samples. Results: NPC cells transfected with miR-9-overexpressing lentivirus, released miR-9 in exosomes. Exosomal miR-9 directly suppressed its target gene - MDK in endothelial cells. Mechanistic analyses revealed that exosomal miR-9 from NPC cells inhibited endothelial tube formation and migration by targeting MDK and regulating PDK/AKT signaling pathway. Additionally, the level of MDK was upregulated in NPC tumor samples and was positively correlated with microvessel density. Notably, the level of exosomal miR-9 was positively correlated with overall survival, and MDK overexpression was positively associated with poor prognosis in NPC patients, suggesting the clinical relevance and prognostic value of exosomal miR-9 and MDK. Conclusions: Taken together, our data identify an extracellular anti-angiogenic role for tumor-derived, exosome-associated miR-9 in NPC tumorigenesis and prompt further investigation into exosome-based therapies for cancer treatment.
引用
收藏
页数:12
相关论文
共 34 条
  • [1] DII4 and PDGF-BB Convert Committed Skeletal Myoblasts to Pericytes without Erasing Their Myogenic Memory
    Cappellari, Ornella
    Benedetti, Sara
    Innocenzi, Anna
    Tedesco, Francesco Saverio
    Moreno-Fortuny, Artal
    Ugarte, Gonzalo
    Lampugnani, Maria Grazia
    Messina, Graziella
    Cossu, Giulio
    [J]. DEVELOPMENTAL CELL, 2013, 24 (06) : 586 - 599
  • [2] Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma
    Choi, Yong Won
    Kim, Young Hwa
    Lee, Jeonghun
    Soh, Euy Young
    Park, Tae Jun
    Kim, Jang-Hee
    [J]. HUMAN PATHOLOGY, 2015, 46 (10) : 1557 - 1565
  • [3] Nasopharyngeal carcinoma
    Chua, Melvin L. K.
    Wee, Joseph T. S.
    Hui, Edwin P.
    Chan, Anthony T. C.
    [J]. LANCET, 2016, 387 (10022) : 1012 - 1024
  • [4] Extracellular vesicles: biology and emerging therapeutic opportunities
    EL Andaloussi, Samir
    Maeger, Imre
    Breakefield, Xandra O.
    Wood, Matthew J. A.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (05) : 348 - 358
  • [5] Midkine in plasma as a novel breast cancer marker
    Ibusuki, Mutsuko
    Fujimori, Hiromi
    Yamamoto, Yutaka
    Ota, Kazutoshi
    Ueda, Mitsuharu
    Shinriki, Satoru
    Taketomi, Masahiro
    Sakuma, Sadatoshi
    Shinohara, Masanori
    Iwase, Hirotaka
    Ando, Yukio
    [J]. CANCER SCIENCE, 2009, 100 (09): : 1735 - 1739
  • [6] Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases
    Jones, D. R.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (12) : 2925 - 2939
  • [7] The biology and function of exosomes in cancer
    Kalluri, Raghu
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (04) : 1208 - 1215
  • [8] Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
    Livak, KJ
    Schmittgen, TD
    [J]. METHODS, 2001, 25 (04) : 402 - 408
  • [9] Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis
    Lu, J.
    Xu, X.
    Liu, X.
    Peng, Y.
    Zhang, B.
    Wang, L.
    Luo, H.
    Peng, X.
    Li, G.
    Tian, W.
    He, M.
    Li, X.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (02) : 392 - 398
  • [10] miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma
    Lu, Juan
    Luo, Huanan
    Liu, Xiong
    Peng, Ying
    Zhang, Bao
    Wang, Lu
    Xu, Xia
    Peng, Xiaohong
    Li, Gang
    Tian, Wendong
    He, Ming-Liang
    Kung, Hsiangfu
    Li, Xiang-Ping
    [J]. CARCINOGENESIS, 2014, 35 (03) : 554 - 563